Practical instructions for using drugs in CT and MR cardiac imaging

Area of Science:

• Radiology
• Cardiovascular Imaging
• Pharmacology

Background:

• Increasing use of noninvasive cardiac imaging like CT coronary angiography (CTCA) and cardiac MR (CMR).
• Need for enhanced radiologist knowledge in drug management for optimal image quality and functional analysis.
• Importance of precise drug administration in CTCA and CMR procedures.

Purpose of the Study:

• To provide a comprehensive overview of drug classes used in CTCA and CMR.
• To detail the indications, contraindications, efficacy, and safety profiles of these drugs.
• To offer practical guidance on drug utilization for improved cardiac imaging outcomes.

Main Methods:

• Review of pharmacological agents employed in CTCA and CMR.
• Analysis of drug mechanisms, metabolism, and potential side effects.
• Synthesis of current literature on drug management in cardiac imaging.

Main Results:

• Detailed description of nitrates, beta-blockers, ivabradine, anxiolytics, adenosine, dobutamine, atropine, dipyridamole, and regadenoson.
• Information on efficacy, safety, and adverse events for each drug class.
• Guidance on optimizing drug selection and administration.

Conclusions:

• Effective drug management is crucial for high-quality CTCA and CMR.
• Understanding drug profiles aids in maximizing diagnostic accuracy and patient safety.
• This review serves as a valuable resource for clinicians managing cardiac imaging pharmacotherapy.